Literature DB >> 3756692

Congenital toxoplasmosis: epidemiologic features and control.

A O Carter, J W Frank.   

Abstract

Toxoplasmosis is caused by the parasite Toxoplasma gondii. It is acquired from undercooked meat or from food or fomites contaminated by cat feces. The disease can be transmitted to the fetus only during maternal parasitemia, which is associated with primary infection. Extrapolation from current data suggests that there are 140 to 1400 cases of congenital toxoplasmosis per year in Canada and that 70 to 280 of the infants are severely affected at birth; many of the others suffer sequelae later in life. Serologic diagnosis of primary infection in the mother is quite sensitive and specific. Diagnosis in the infant is more difficult and may take several months. Prenatal treatment of the woman and postnatal treatment of the infant are hampered by the lack of proven efficacy as well as ethical and compliance problems. Preventive serologic screening and prophylaxis have the same drawbacks. Educating young women to avoid infection is an inexpensive, low-risk intervention that would be the preferred preventive strategy if it could be shown to be effective. Immunization may prove to be the most cost-effective method of preventing congenital toxoplasmosis if a safe and effective vaccine is developed.

Entities:  

Mesh:

Year:  1986        PMID: 3756692      PMCID: PMC1491297     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  31 in total

1.  A survey of toxoplasmosis in an Ontario community.

Authors:  G E FFRENCH; N A FISH
Journal:  Can Med Assoc J       Date:  1961-04-08       Impact factor: 8.262

Review 2.  Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease.

Authors:  C A Alford; S Stagno; D W Reynolds
Journal:  Bull N Y Acad Med       Date:  1974-02

3.  Prevalence of toxoplasmosis in a Canadian city.

Authors:  S K Seah
Journal:  Can J Public Health       Date:  1973-10

4.  Breaking the transmission chain of Toxoplasma: a program for the prevention of human toxoplasmosis.

Authors:  J K Frenkel
Journal:  Bull N Y Acad Med       Date:  1974-02

5.  Latent toxoplasmosis and pregnancy.

Authors:  M Sharf; I Eibschitz; E Eylan
Journal:  Obstet Gynecol       Date:  1973-09       Impact factor: 7.661

6.  Congenital toxoplasmosis. A prospective study of 378 pregnancies.

Authors:  G Desmonts; J Couvreur
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

7.  Toxoplasmosis and its prevention in cats and man.

Authors:  J K Frenkel; J P Dubey
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

8.  Toxoplasmosis in pregnancy.

Authors:  C F Ruoss; G L Bourne
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-12

9.  Congenital toxoplasmosis: a prospective study of 4,048 obstetric patients.

Authors:  A C Kimball; B H Kean; F Fuchs
Journal:  Am J Obstet Gynecol       Date:  1971-09-15       Impact factor: 8.661

10.  Toxoplasmosis. A cause of infertility.

Authors:  B Eckerling; A Neri; E Eylan
Journal:  Fertil Steril       Date:  1968 Nov-Dec       Impact factor: 7.329

View more
  14 in total

1.  Toxoplasma gondii toxolysin 4 is an extensively processed putative metalloproteinase secreted from micronemes.

Authors:  Julie Laliberté; Vern B Carruthers
Journal:  Mol Biochem Parasitol       Date:  2011-01-26       Impact factor: 1.759

2.  A Toxoplasma gondii leucine-rich repeat protein binds phosphatase type 1 protein and negatively regulates its activity.

Authors:  Wassim Daher; Gabrielle Oria; Sylvain Fauquenoy; Katia Cailliau; Edith Browaeys; Stanislas Tomavo; Jamal Khalife
Journal:  Eukaryot Cell       Date:  2007-07-27

Review 3.  Host cell manipulation by the human pathogen Toxoplasma gondii.

Authors:  J Laliberté; V B Carruthers
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

4.  Common questions about the diagnosis and management of congenital toxoplasmosis.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-03       Impact factor: 2.253

5.  Screening in pregnancy.

Authors:  A Biringer
Journal:  Can Fam Physician       Date:  1988-09       Impact factor: 3.275

6.  The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis.

Authors:  A O Carter; S B Gelmon; G A Wells; A P Toepell
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

7.  Status of toxoplasma antibodies in recurrent fetal loss in U.A.E. women.

Authors:  N Singh
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

Review 8.  Effects of antibacterials on the unborn child: what is known and how should this influence prescribing.

Authors:  A Einarson; S Shuhaiber; G Koren
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

9.  Everyday and exotic foodborne parasites.

Authors:  M B Lee
Journal:  Can J Infect Dis       Date:  2000-05

10.  Toxoplasmosis and Toxocariasis: An Assessment of Human Immunodeficiency Virus Comorbidity and Health-Care Costs in Canada.

Authors:  Janna M Schurer; Ellen Rafferty; Michael Schwandt; Wu Zeng; Marwa Farag; Emily J Jenkins
Journal:  Am J Trop Med Hyg       Date:  2016-05-02       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.